A detailed history of Pro Vise Management Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 18,874 shares of AMGN stock, worth $5.96 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
18,874
Previous 19,235 1.88%
Holding current value
$5.96 Million
Previous $5.47 Million 7.85%
% of portfolio
0.51%
Previous 0.48%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $94,852 - $115,270
-361 Reduced 1.88%
18,874 $5.9 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $590,707 - $713,058
-2,197 Reduced 10.25%
19,235 $5.47 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $97,421 - $109,903
-381 Reduced 1.75%
21,432 $6.17 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $72,810 - $90,396
-333 Reduced 1.5%
21,813 $5.86 Million
Q2 2023

Aug 24, 2023

BUY
$214.27 - $253.37 $47,353 - $55,994
221 Added 1.01%
22,146 $4.92 Million
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $128,022 - $156,038
-567 Reduced 2.52%
21,925 $5.3 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $419,124 - $532,548
1,830 Added 8.86%
22,492 $5.91 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $520,298 - $586,801
2,318 Added 12.64%
20,662 $4.66 Million
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $683,363 - $760,463
2,962 Added 19.26%
18,344 $4.46 Million
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $761,524 - $842,445
3,473 Added 29.16%
15,382 $3.72 Million
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $112,764 - $129,049
-567 Reduced 4.54%
11,909 $2.68 Million
Q3 2021

Oct 20, 2021

BUY
$212.27 - $248.7 $259,393 - $303,911
1,222 Added 10.86%
12,476 $2.65 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $54,190 - $60,120
232 Added 2.1%
11,254 $2.74 Million
Q1 2021

Apr 22, 2021

SELL
$221.91 - $258.6 $1,553 - $1,810
-7 Reduced 0.06%
11,022 $2.74 Million
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $4,976 - $5,926
23 Added 0.21%
11,029 $2.54 Million
Q3 2020

Oct 26, 2020

SELL
$234.65 - $260.95 $95,502 - $106,206
-407 Reduced 3.57%
11,006 $2.8 Million
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $126,202 - $154,868
-638 Reduced 5.29%
11,413 $2.69 Million
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $34,807 - $46,164
-191 Reduced 1.56%
12,051 $2.44 Million
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $69,061 - $88,768
365 Added 3.07%
12,242 $2.95 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $70,340 - $84,282
404 Added 3.52%
11,877 $2.3 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $6.49 Million - $7.6 Million
-38,906 Reduced 77.23%
11,473 $2.11 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $365,538 - $412,041
-2,021 Reduced 3.86%
50,379 $9.57 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $298,820 - $348,818
-1,675 Reduced 3.1%
52,400 $10.2 Million
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $113,026 - $127,422
-610 Reduced 1.12%
54,075 $11.2 Million
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $112,914 - $126,826
680 Added 1.26%
54,685 $20.2 Million
Q1 2018

May 09, 2018

SELL
$169.43 - $198.0 $5,930 - $6,930
-35 Reduced 0.06%
54,005 $9.21 Million
Q4 2017

Feb 07, 2018

BUY
$168.79 - $188.59 $170,984 - $191,041
1,013 Added 1.91%
54,040 $9.4 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $8.87 Million - $10.1 Million
53,027
53,027 $9.89 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.